Track topics on Twitter Track topics that are important to you
The humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years 2016 to 2021.
Growing adoption of personalized medicine to fuel the demand for personalized mice models, continuous support in the form of investments and grants from the government and private sectors, and increase in RD activities carried out by pharmaceutical and biotechnology companies are the key factors driving the growth of the market. However, regulations laws formulated for ethical use of animals and increased use of rat models are restraining the growth of the market to a certain extent.
The global humanized mouse model market is segmented on the basis of type, application, end user, and region. In 2016, North America is expected to account for the largest share of the global humanized mouse model market, followed by Europe, AsiaPacific, and the Rest of the World RoW. AsiaPacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as increasing investments from the government and private sector in China, growing biomedical and medical research industry in Japan, growing presence of global players in India, and increasing pharmaceutical and biotech RD activities in Korea.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies product launches, collaborations, agreements, partnerships, alliances, grants, licensing, contracts, acquisitions, and expansions to increase their market shares and establish a strong foothold in the global market.
Indepth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the humanized mouse model market place.
By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
By Designation: Director Level: 58%, Clevel: 25%, Others: 17%
By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%
Key players in the global humanized mouse model market include The Jackson Laboratory U.S., Taconic Biosciences, Inc. U.S., Harbour Antibodies BV China, HuMurine Technologies, Inc. U.S., Vitalstar Biotechnology Co. Ltd. China, Crown Bioscience, Inc. U.S., ingenious targeting laboratory U.S., Axenis S.A.S France, TRANS GENIC, Inc. Japan, genOway S.A. France, and Horizon Discovery Group plc U.K..
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the belowmentioned five strategies market penetration, product development/innovation, market development, market diversification, and competitive assessment for strengthening their market shares.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the products and services offered by top players in the humanized mouse model market. The report analyzes the humanized mouse market by type, application, and end user.
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the humanized mouse model market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for humanized mouse model across regions
Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the humanized mouse model market
Competitive Assessment: Indepth assessment of market shares, strategies, products, and distribution networks of the leading players in the humanized mouse model market
Original Article: Humanized Mouse Model Market by Type Genetic, Cellbased CD34, PBMC, BLT, Application Neuroscience, Hematopoiesis, Oncology, Immunology Infectious diseases End UserPharmaceutical Biotech Companies, CRO Global Forecast to 2021 [Updated: 23012017] PricesNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.